BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 17848739)

  • 21. Concentration of interleukin-6 (IL-6), interleukin-8 (IL-8) and interleukin-10 (IL-10) in blood serum of breast cancer patients.
    Kozłowski L; Zakrzewska I; Tokajuk P; Wojtukiewicz MZ
    Rocz Akad Med Bialymst; 2003; 48():82-4. PubMed ID: 14737948
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TNF receptor p55 and IL-8(72) and IL-8(77) isoforms: blood and urine levels in breast cancer patients.
    Shichkin VP; Lon AD; Yugrinova LG; Grinevich YA; Belova OB; Berezhnaya NM; Akalovich S; Pashkova O; Voitenok NN
    J Immunotoxicol; 2009 Dec; 6(4):235-42. PubMed ID: 19908942
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum levels of IL-6, IL-8 and CRP as prognostic factors in epithelial ovarian cancer.
    Dobrzycka B; Mackowiak-Matejczyk B; Terlikowska KM; Kulesza-Bronczyk B; Kinalski M; Terlikowski SJ
    Eur Cytokine Netw; 2013; 24(3):106-13. PubMed ID: 24197277
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical significance of interleukin-4 and interleukin-18 levels in aggressive non-Hodgkin's lymphoma patients.
    Soydinc HO; Guney N; Basaran M; Duranyildiz D; Yasasever V
    Genet Mol Res; 2016 Jul; 15(3):. PubMed ID: 27525895
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictive value of serum interleukin-8 levels in ovarian cancer patients treated with paclitaxel-containing regimens.
    Uslu R; Sanli UA; Dikmen Y; Karabulut B; Ozsaran A; Sezgin C; Muezzinoglu GG; Omay SB; Goker E
    Int J Gynecol Cancer; 2005; 15(2):240-5. PubMed ID: 15823106
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased levels of interleukins 8 and 10 as findings of canine inflammatory mammary cancer.
    de Andrés PJ; Illera JC; Cáceres S; Díez L; Pérez-Alenza MD; Peña L
    Vet Immunol Immunopathol; 2013 Apr; 152(3-4):245-51. PubMed ID: 23351639
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of serum interleukin-18 as a prognostic factor in patients with hepatocellular carcinoma.
    Tangkijvanich P; Thong-Ngam D; Mahachai V; Theamboonlers A; Poovorawan Y
    World J Gastroenterol; 2007 Aug; 13(32):4345-9. PubMed ID: 17708609
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Simultaneous measurement of multiple Th1 and Th2 serum cytokines in psoriasis and correlation with disease severity.
    Jacob SE; Nassiri M; Kerdel FA; Vincek V
    Mediators Inflamm; 2003 Oct; 12(5):309-13. PubMed ID: 14760939
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical Significance of Serum Membrane-Bound Mucin-2 Levels in Breast Cancer.
    Bademler S; Zirtiloglu A; Sari M; Ucuncu MZ; Dogru EB; Karabulut S
    Biomolecules; 2019 Jan; 9(2):. PubMed ID: 30682816
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum interleukin-12 and interleukin-18 levels as a tumor marker in patients with esophageal carcinoma.
    Tsuboi K; Miyazaki T; Nakajima M; Fukai Y; Masuda N; Manda R; Fukuchi M; Kato H; Kuwano H
    Cancer Lett; 2004 Mar; 205(2):207-14. PubMed ID: 15036653
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic significance of changes in CA 15-3 serum levels during chemotherapy in metastatic breast cancer patients.
    Tampellini M; Berruti A; Bitossi R; Gorzegno G; Alabiso I; Bottini A; Farris A; Donadio M; Sarobba MG; Manzin E; Durando A; Defabiani E; De Matteis A; Ardine M; Castiglione F; Danese S; Bertone E; Alabiso O; Massobrio M; Dogliotti L
    Breast Cancer Res Treat; 2006 Aug; 98(3):241-8. PubMed ID: 16670941
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum IL-6 and IL-8 Correlate with Prognostic Factors in Ovarian Cancer.
    Sanguinete MMM; Oliveira PH; Martins-Filho A; Micheli DC; Tavares-Murta BM; Murta EFC; Nomelini RS
    Immunol Invest; 2017 Oct; 46(7):677-688. PubMed ID: 28872976
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum interleukin-12 levels in patients with gastric cancer.
    Murakami S; Okubo K; Tsuji Y; Sakata H; Hamada S; Hirayama R
    Surg Today; 2004; 34(12):1014-9. PubMed ID: 15580384
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum interleukin-12 and interleukin-18 levels in patients with oesophageal squamous cell carcinoma.
    Diakowska D; Markocka-Maczka K; Grabowski K; Lewandowski A
    Exp Oncol; 2006 Dec; 28(4):319-22. PubMed ID: 17285118
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interleukin-8 as a prognostic serum marker in canine mammary gland neoplasias.
    Gelaleti GB; Jardim BV; Leonel C; Moschetta MG; Zuccari DA
    Vet Immunol Immunopathol; 2012 Apr; 146(2):106-12. PubMed ID: 22405680
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The prognostic role of interleukin-8 (IL-8) and matrix metalloproteinases -2 and -9 in lymph node-negative untreated breast cancer patients.
    Milovanovic J; Todorovic-Rakovic N; Abu Rabi Z
    J BUON; 2013; 18(4):866-73. PubMed ID: 24344010
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum sonic hedgehog (SHH) and interleukin-(IL-6) as dual prognostic biomarkers in progressive metastatic breast cancer.
    Noman AS; Uddin M; Chowdhury AA; Nayeem MJ; Raihan Z; Rashid MI; Azad AK; Rahman ML; Barua D; Sultana A; Shirin A; Ferdous J; Parag RR; Rahman SM; Mahmud MR; Jerin CS; Jahan N; Siddiqua A; Ara T; Sabur EB; Alam SS; Baidya S; Akther S; Rahman MZ; Banu T; Murugan AK; Sabri S; Islam SMS; Karakas B; Aboussekhra A; Yeger H; Farhat WA; Islam SS
    Sci Rep; 2017 May; 7(1):1796. PubMed ID: 28496132
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circulating interleukin (IL)-8, IL-2R, IL-12, and IL-15 levels are independently prognostic in primary myelofibrosis: a comprehensive cytokine profiling study.
    Tefferi A; Vaidya R; Caramazza D; Finke C; Lasho T; Pardanani A
    J Clin Oncol; 2011 Apr; 29(10):1356-63. PubMed ID: 21300928
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of interleukine-8 as an independent prognostic factor for sporadic colon cancer dissemination.
    Nastase A; Paslaru L; Herlea V; Ionescu M; Tomescu D; Bacalbasa N; Dima S; Popescu I
    J Med Life; 2014 Jun; 7(2):215-9. PubMed ID: 25408728
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The value of serum levels of IL-6, TNF-alpha, and erythropoietin in metastatic malignant melanoma: serum IL-6 level is a valuable prognostic factor at least as serum LDH in advanced melanoma.
    Tas F; Oguz H; Argon A; Duranyildiz D; Camlica H; Yasasever V; Topuz E
    Med Oncol; 2005; 22(3):241-6. PubMed ID: 16110135
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.